Baxter Corporation IV Solutions Recall 2026 — Blue Cap Breakage Risk

Baxter Corporation has issued a health product recall affecting multiple intravenous (IV) injectable and irrigation solutions distributed across Canadian healthcare establishments. The recall, identified under Health Canada reference number RA-82181, was issued on June 8, 2026, due to a packaging defect in which the Blue Caps Enhanced Closures (blue tip protectors) may break apart in affected lots, posing a potential contamination and patient safety risk.

What Products Are Being Recalled?

The recall affects four Baxter Corporation IV solution products, all in solution dosage form. The affected products and their corresponding lot numbers are as follows:

• 0.9% Sodium Chloride Injection, USP (DIN 00060208) — Strength: Sodium chloride 900 mg/100 mL — Lot Numbers: W6A14B0, W6B04B0, W6C05B0, W6C06B0, W6C11B0, W5L16M0, W5L16M0A, W5L16M0S, W6A14A0, W6A16A0, W6A18A0, W6A28M0, W6A28M0A, W6B05M0, W6B05M0A, W6B08A0, W6B21A1
• 0.9% Sodium Chloride Irrigation, USP (DIN 00786160) — Strength: Sodium chloride 900 mg/100 mL — Lot Number: W6C11T1
• (20 mmol/L) Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection, USP (DIN 00786292) — Lot Number: W6C05A1
• Lactated Ringer’s Injection, USP (DIN 00061085) — Lot Number: W6C05A0

All products are manufactured and distributed by Baxter Corporation, headquartered at 7125 Mississauga Rd, Mississauga, ON L5N 0C2, Canada.

Why Was This Recall Issued?

The recall was triggered by a confirmed packaging defect. The Blue Caps Enhanced Closures — the blue tip protectors used on these IV solution containers — may break apart in the affected lot numbers. When these protective caps fracture or fragment, there is a risk that broken pieces could compromise the sterile seal of the container, potentially leading to contamination of the solution. This is classified as a Type III recall under Health Canada guidelines, indicating a situation where use of or exposure to a violative product is not likely to cause adverse health consequences, but where a recall is still warranted to maintain product integrity and patient safety standards.

Who Is Affected?

This recall is directed at healthcare establishments across Canada, including hospitals, clinics, and other medical facilities that may have received and stored the affected lot numbers. The audience identified by Health Canada includes healthcare professionals and industry stakeholders. Patients receiving IV therapy with any of the recalled lot numbers at a healthcare facility should consult their healthcare provider immediately if they have any concerns about their treatment.

What Should You Do?

• Check your inventory to verify whether any of the affected lot numbers are present in your facility or possession.
• Do not discontinue use of a medically necessary product without first consulting your healthcare provider, as abrupt cessation of IV therapy may carry its own clinical risks.
• Contact Baxter Corporation directly if you have questions regarding the recall or need to arrange return or replacement of affected products.
• Report any adverse health effects or side effects potentially related to this product to Health Canada via the MedEffect Canada adverse reaction reporting system.
• Report any other health product safety complaints to Health Canada through the designated online complaints portal.

Official Statement

Health Canada, which published this recall alert, has confirmed that the recall depth extends to healthcare establishments. The regulatory authority categorises this under ‘Health Products — Drugs’ and has assigned it recall identification number RA-82181. Baxter Corporation is cooperating with the recall and is the responsible recalling firm. Consumers and healthcare professionals are encouraged to subscribe to Health Canada recall notifications at recalls-rappels.canada.ca to stay informed of future safety alerts. For any health or safety concerns related to this product, individuals may also use the Government of Canada’s official ‘Report a health or safety concern’ service online.